A review on protein misfolding, aggregation and strategies to prevent related ailments

Int J Biol Macromol. 2017 Dec;105(Pt 1):993-1000. doi: 10.1016/j.ijbiomac.2017.07.116. Epub 2017 Jul 23.

Abstract

This review aims to highlight the fundamental mechanism of protein misfolding leading to protein aggregation and associated diseases. It also aims to anticipate novel therapeutic strategies with which to prevent or treat these highly debilitating conditions linked to these pathologies. The failure of a protein to correctly fold de novo or to remain correctly folded can have profound consequences on a living system especially when the cellular quality control processes fail to eliminate the rogue proteins. The core cause of over 20 different human diseases which have now been designated as 'conformational diseases' including neurodegenerative diseases such as Alzheimer's disease (AD), Huntington's disease (HD) and Parkinson's disease (PD) etc. A comprehensive study on protein misfolding, aggregation, and the outcomes of the effects of cytotoxic aggregates will lead to understand the aggregation-mediated cell toxicity and serves as a foundation for future research in development of promising therapies and drugs. This review has also shed light on the mechanism of protein misfolding which leads to its aggregation and hence the neurodegeneration. From these considerations, one could also envisage the possibility that protein aggregation may be exploited by nature to perform specific physiological functions in differing biological contexts.

Keywords: Neurodegenerative diseases; Protein aggregation; Protein misfolding.

Publication types

  • Review

MeSH terms

  • Amyloid / chemistry
  • Animals
  • Humans
  • Neurodegenerative Diseases / prevention & control
  • Neurodegenerative Diseases / therapy
  • Protein Aggregates* / drug effects
  • Protein Folding / drug effects
  • Proteostasis Deficiencies / prevention & control*
  • Proteostasis Deficiencies / therapy

Substances

  • Amyloid
  • Protein Aggregates